Other warning signs include extreme tiredness, loss of appetite, and a general feeling of being unwell. These symptoms are ...
For the first time in 30 years, the Food and Drug Administration has approved a new treatment for an inoperable type of pancreatic cancer.
A research-supported, seven-part system developed from clinical practice and Dr. Jacobs’ own healing journey Pain is ...
President Donald Trump called it a matter of national defense. But Make America Healthy Again activists say he broke their trust.
Shares in the company lost about half their value in Friday trading after the clinical trial failed to demonstrate a statistically significant reduction in stage III and IV cancers.
A large, long-term study following nearly 1 million adults across the United States and Europe has found that dietary ...
NEW YORK – The US Food and Drug Administration has accepted Roche subsidiary Genentech's new drug application for giredestrant in combination with the mTOR inhibitor Afinitor (everolimus) for estrogen ...
The organization presented data aggregated from multiple clinical trials to explore ctDNA's potential as a surrogate endpoint predictive of treatment benefit in lung and other cancers.
Pharmalittle: We’re reading about an FDA official’s speech, a Grail cancer blood test, and much more
The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV ...
A closely watched clinical trial in Britain that screened blood for early detection of cancer did not show a reduction in ...
"This is not a chemical with zero risk," Melissa Perry, a professor of public health at George Mason University, told ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results